BioSpace News Archive

The Cancer Support Community will present Incyte with the Founders Award for Innovation at its signature event slated for Tuesday, April 16 at The Lighthouse on Pier 61, part of the acclaimed Chelsea Piers complex on New York City’s Hudson River waterfront.

Santhera Pharmaceuticals (SIX: SANN) announces that it has placed all of the remaining 500,000 registered shares from its existing authorized share capital in a private placement, resulting in aggregate gross proceeds of CHF 7.1 million.

The U.S. Food and Drug Administration and the U.S. Customs and Border Protection leaders signed an agreement to maximize inspection and detection capabilities in order to prevent illegal and harmful products entering the U.S. through the nation’s International Mail Facilities and Ports of Entry that pose a threat to public health.

The U.S. Food and Drug Administration is extending the indication of Ibrance capsules in combination with specific endocrine therapies for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer in male patients.

On behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, Peter Fragiskatos, Member of Parliament, will announce federal support for a healthy lifestyle project that will benefit men across Canada.

New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents

In recognition of the continued collaboration and performance resulting in improved outcomes provided to Maryland’s Medicaid beneficiaries, the Maryland Department of Health has extended two contracts with Telligen.

Safety update shows Phase 1 study unable to reach optimal therapeutic index for MM-310 due to continued observation of cumulative peripheral neuropathy

Syros Pharmaceuticals announced that it is offering to sell, subject to market and other conditions, shares of its common stock and Class A warrants to purchase common stock, and shares of its Series A convertible preferred stock and Class A warrants to purchase common stock, in two concurrent but separate underwritten public offerings.

Baxter International Inc., a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.